Tamsulosin Hydrochloride NDC 72162-2502

NDC codes

FDA NDC Directory

Product NDC (as listed)72162-2502Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72162-2502Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72162-2502-0	72162250200	1000 CAPSULE in 1 BOTTLE (72162-2502-0)Marketed from May 15, 2025
72162-2502-1	72162250201	100 CAPSULE in 1 BOTTLE (72162-2502-1)Marketed from May 15, 2025
72162-2502-5	72162250205	500 CAPSULE in 1 BOTTLE (72162-2502-5)Marketed from May 15, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tamsulosin Hydrochloride
Generic name (nonproprietary): tamsulosin hydrochloride
Active ingredients: Tamsulosin hydrochloride — .4 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204645
Marketing start: Jan 25, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 72162-2502_377764cf-e917-e525-e063-6394a90a4d28SPL ID 377764cf-e917-e525-e063-6394a90a4d28SPL set ID 3533e74e-5706-f594-e063-6394a90ab8a7RxCUI 863669UNII 11SV1951MR
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162250200 followed by a unit qualifier and the quantity

Package 72162-2502-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 13, 2025.

Indications (excerpt from the label)

Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies ( 14 )]. Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension. • Tamsulosin hydrochloride is an alpha 1 adrenoceptor antagonist indicated for treatment of the signs and symptoms of benign prostatic hyperplasia ( 1 ) • Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204645

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204645
Product	Strength	Form · route	Labeler	Product NDC
Tamsulosin Hydrochloride	Tamsulosin hydrochloride .4 mg/1	CapsuleOral	Macleods Pharmaceuticals Limited	33342-159
Tamsulosin Hydrochloride	Tamsulosin hydrochloride .4 mg/1	CapsuleOral	NuCare Pharmaceuticals,Inc.	68071-4872
Tamsulosin Hydrochloride	Tamsulosin hydrochloride .4 mg/1	CapsuleOral	NuCare Pharmaceuticals,Inc.	68071-1840